2018 德国子宫内膜癌跨学科诊断,治疗以及随访指南

2018-10-07 德国妇科肿瘤小组 Geburtshilfe Frauenheilkd. 2018 Oct;78(10):949-971

2018 德国子宫内膜癌跨学科诊断,治疗以及随访指南于2018年11月发布,主要目的是为子宫内膜的管理提供循证临床指导意见。 2018 德国子宫内膜癌跨学科诊断,治疗以及随访指南

中文标题:

2018 德国子宫内膜癌跨学科诊断,治疗以及随访指南

英文标题:

Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Nummer 032/034-OL, April 2018) - Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary

发布机构:

德国妇科肿瘤小组

发布日期:

2018-10-07

简要介绍:

2018 德国子宫内膜癌跨学科诊断,治疗以及随访指南于2018年11月发布,主要目的是为子宫内膜的管理提供循证临床指导意见。 2018 德国子宫内膜癌跨学科诊断,治疗以及随访指南 


拓展指南:子宫内膜癌相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2018 德国子宫内膜癌跨学科诊断,治疗以及随访指南)] GetToolGuiderByIdResponse(projectId=1, id=08f6e1c00166080b, title=2018 德国子宫内膜癌跨学科诊断,治疗以及随访指南, enTitle=Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Nummer 032/034-OL, April 2018) - Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary, guiderFrom=Geburtshilfe Frauenheilkd. 2018 Oct;78(10):949-971, authorId=null, author=, summary=2018 德国子宫内膜癌跨学科诊断,治疗以及随访指南于2018年11月发布,主要目的是为子宫内膜的管理提供循证临床指导意见。 2018 德国子宫内膜癌跨学科诊断,治疗以及随访指南 , cover=, journalId=null, articlesId=null, associationId=1692, associationName=德国妇科肿瘤小组, associationIntro=, copyright=0, guiderPublishedTime=Sun Oct 07 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=2018 德国子宫内膜癌跨学科诊断,治疗以及随访指南于2018年11月发布,主要目的是为子宫内膜的管理提供循证临床指导意见。 2018 德国子宫内膜癌跨学科诊断,治疗以及随访指南  <div><br> </div>拓展指南:<strong>与<font color=red>子宫内膜癌</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=1b79e1c00163e149" title="子宫内膜癌诊断与治疗指南(第四版)" target=_blank>子宫内膜癌诊断与治疗指南(第四版)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=de3c21c0016158f1" title="2018 ESUR指南:子宫内膜癌MRI分期(更新)" target=_blank>2018 ESUR指南:子宫内膜癌MRI分期(更新)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=f550d1c0015262de" title="子宫内膜癌筛查和早期诊断专家共识(草案)" target=_blank>子宫内膜癌筛查和早期诊断专家共识(草案)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=84e111c00133e072" title="2016 KSGO共识声明:子宫内膜癌的管理实践指南" target=_blank>2016 KSGO共识声明:子宫内膜癌的管理实践指南</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=2770d1c0013151af" title="2015 ACOG/SGO临床指南(NO.149):子宫内膜癌" target=_blank>2015 ACOG/SGO临床指南(NO.149):子宫内膜癌</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E5%AD%90%E5%AE%AB%E5%86%85%E8%86%9C%E7%99%8C" target=_blank>有关子宫内膜癌更多指南</a></ul>, tagList=[TagDto(tagId=850, tagName=子宫内膜癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6396, appHits=262, showAppHits=13, pcHits=4433, showPcHits=2149, likes=109, shares=3, comments=3, approvalStatus=1, publishedTime=Wed Nov 07 22:18:13 CST 2018, publishedTimeString=2018-10-07, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed Nov 07 22:18:13 CST 2018, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 16:28:19 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 德国子宫内膜癌跨学科诊断,治疗以及随访指南)])
2018 德国子宫内膜癌跨学科诊断,治疗以及随访指南
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=954471, encodeId=e5bb9544e1af, content=受益匪浅!好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:04:53 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954768, encodeId=0bb2954e689e, content=已看,还可以。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 15:09:11 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954595, encodeId=bd9b9545952c, content=资料好好,但无法分享,遗憾!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 13:50:17 CST 2021, time=2021-04-07, status=1, ipAttribution=)]
    2021-04-07 湘雅科教

    受益匪浅!好文章。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=954471, encodeId=e5bb9544e1af, content=受益匪浅!好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:04:53 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954768, encodeId=0bb2954e689e, content=已看,还可以。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 15:09:11 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954595, encodeId=bd9b9545952c, content=资料好好,但无法分享,遗憾!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 13:50:17 CST 2021, time=2021-04-07, status=1, ipAttribution=)]
    2021-04-07 ms6000001015893838

    已看,还可以。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=954471, encodeId=e5bb9544e1af, content=受益匪浅!好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:04:53 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954768, encodeId=0bb2954e689e, content=已看,还可以。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 15:09:11 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954595, encodeId=bd9b9545952c, content=资料好好,但无法分享,遗憾!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 13:50:17 CST 2021, time=2021-04-07, status=1, ipAttribution=)]
    2021-04-07 ms6000001015893838

    资料好好,但无法分享,遗憾!

    0